Access cutting-edge breast cancer treatment through this clinical trial at a research site in Columbus. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Columbus at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This phase II trial evaluates tamoxifen, with or without omega-3 fatty acids, for reducing risk of breast cancer among postmenopausal and overweight or obese women who are at increased risk of developing breast cancer. Tamoxifen is a selective estrogen receptor modulator. It works by blocking the effects of the hormone estrogen in the breast. Tamoxifen is approved by the Food and Drug Administration for prevention of breast cancer in women at increased risk. Omega-3 fatty acids have been shown t
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this breast cancer clinical trial in Columbus, OH
If you're searching for breast cancer treatment options in Columbus, OH, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Columbus research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.